Kelli Kraft, MN, ARNP, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1190 Riddle Street, Darrington, WA 98241 Phone: 360-436-1055 Fax: 360-436-0146 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.
Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre.
Researchers at the Shiley-Marcos Alzheimer's Disease Research Center at the University of California San Diego are about to launch a Phase 2 clinical trial to test a gene therapy treatment for Alzheimer's disease (AD) called CERE-110.
› Verified 9 days ago